Lancet 382:339352 Thomas MC, Cooper ME, Zimmet P (2016) Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
I think of this as more of a relief than a burden, Salas-Whalen says
Because the review of 48 studies, although comprehensive, looked at a wide and diverse group of people -- from those with conditions such as diabetes and kidney disease, and those with different starting and end points and who took different medications -- the conclusions drawn also highlight its limitations
Functional MRI activation of the nucleus tractus solitarius after taste stimuli at ultra-high field: a proof-of-concept single-subject study
GLP-1 receptor activation in the kidneys increases sodium excretion through inhibition of the sodium-hydrogen ion exchanger in the proximal tubule
Your insurance covers GLP-1 medications but not dual agonists